Neuralstem announces final results of neuralstem Phase 1 stem cell trial. Neuralstem, Inc. (NYSEMKT:CUR) announced that the final results from the Phase I safety trial using NSI-566 spinal cord stem cells in the treatment of amyotrophic lateral sclerosis were published in the peer-reviewed journal, “Annals of Neurology”. The results showed that NSI-566 human spinal cord stem cells can be safely transplanted in both the lumbar and cervical spinal cord segments, did not accelerate disease progression, and warrant further study on dosing and therapeutic efficacy. Neuralstem, Inc. (NYSEMKT:CUR) shares after opening at $4.48 moved to $4.80 on last trade day and at the end of the day closed at $4.17. Company price to sales ratio in past twelve months was calculated as 3043.56 and price to cash ratio as 18.56. Neuralstem, Inc. (NYSEMKT:CUR) showed a negative weekly performance of -4.58%.
Washington, D.C.-based Vanda Pharmaceuticals Inc (NASDAQ:VNDA), has launched a couple of drugs and even recently put into place a television ad campaign. The company is now in need of extra space and will expand into an additional 8,600 square feet at its D.C. headquarters located at 2200 Pennsylvania Avenue. Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) shares fell -8.50% in last trading session and ended the day on $17.12. VNDA return on equity ratio is recorded as -76.90% and its return on assets is -15.00%. Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) yearly performance is 333.42 %.
Cowen Group Inc (NASDAQ:COWN) saw a big move last session, as the company’s shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for COWN as the stock is now up more than 4% in the past one-month time frame. Cowen Group Inc (NASDAQ:COWN) shares moved down -1.26% in last trading session and was closed at $ 4.70, while trading in range of $4.59 – 4.83 . Cowen Group Inc, (NASDAQ:COWN) year to date (YTD) performance is 20.20%.
Cloud Peak Energy Inc. (NYSE:CLD) is up over 7.9% in the past four weeks, investors may be concerned. After all, CLD is now in overbought territory, at least when looking at its RSI value of 71.4. If that wasn’t enough, investors should also note that Cloud Peak possesses a Zacks Rank #4 (Sell), so if analyst perception is any guide, we could witness a slump in CLD shares before too long. Cloud Peak Energy Inc.(NYSE:CLD) weekly performance is 2.47%. On last trading day company shares ended up $20.31. Cloud Peak Energy Inc. (NYSE:CLD) distance from 50-day simple moving average (SMA50) is 8.91%. Analysts mean target price for the company is $20.54.